Steven Cohen’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Steven Cohen’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-319,500	Closed	-$8.29M	–	3015
2023 Q2	$8.29M	Buy	319,500 +80,381	+34%	+$1.88M	0.02%	647
2023 Q1	$4.51M	Sell	239,119 -513,381	-68%	-$11.9M	0.01%	793
2022 Q4	$18.5M	Buy	752,500 +295,400	+65%	+$8.68M	0.06%	354
2022 Q3	$8.21M	Sell	457,100 -242,000	-35%	-$4.36M	0.03%	564
2022 Q2	$7.93M	Buy	+699,100	New	+$10.3M	0.03%	573

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Steven Cohen's INBX Position: Q3 2023 in Review

Steven Cohen sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2023, closing a stake of 319,500 shares — an estimated $8.29M sold.

Steven Cohen first reported a position in INBX in Q2 2022 and held it in 5 quarters. The position peaked at $18.5M in Q4 2022. 111 funds tracked by Wall St. Rank hold INBX as of Q3 2023.

Steven Cohen reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Steven Cohen sold 319,500 Inhibrx, Inc. Common Stock shares in Q3 2023, an estimated $8.29M.
Steven Cohen first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Steven Cohen's Inhibrx, Inc. Common Stock position peaked at $18.5M in Q4 2022.
111 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.